Neoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response: A pilot study.
Phase of Trial: Phase III
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Anthracyclines; Docetaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms SETUP
- 08 Jun 2016 Planned number of patients changed from 50 to 180.
- 12 May 2009 Status changed from not stated to recruiting.
- 12 May 2009 New trial record